Woman 63 breast metastatic cancer HER 2+, excellente response to docetaxel plus trastuzumab pertuzumab, should inexcusably continue treatment with trastu pertu when docetaxel cicles are over?
Notes about answers
If you see something you feel is wrong, don’t criticise (that misses the point of Triple) courteously and supportively give a counter answer.
Answers given should be in good faith, but they should not be considered definitive, be critical.
We do not endorse or verify content posted by users.
Thanks for your response,
Thanks for your question,